Zobrazeno 1 - 10
of 843
pro vyhledávání: '"A. Esposito-Del Puente"'
Autor:
Libuse Tauchmanovà, A Esposito-del Puente, V. Nuzzo, Riccardo Rossi, Gaetano Lombardi, Claudia Pizzi, Giovanni Lupoli, Francesco Fonderico, A. Del Puente
Publikováno v:
European Journal of Endocrinology. :241-247
OBJECTIVE: Glucocorticoid excess is widely recognized as one of the most important causes of bone loss. The mechanism of glucocorticoid-induced osteoporosis is presumably multifactorial, and consists of the loss of organic and non-organic compounds.
Autor:
Lasher, Alexander Tate1 (AUTHOR), Liu, Kaimao1 (AUTHOR), Fitch, Michael P1 (AUTHOR), Sun, Liou Y.1 (AUTHOR) sunlab@uab.edu
Publikováno v:
Aging Cell. Dec2024, Vol. 23 Issue 12, p1-6. 6p.
Autor:
Libuse Tauchmanovà, Francesco Fonderico, Antonella Esposito-del Puente, Antonio Del Puente, Giovanni Lupoli, Giuseppe Bifulco, Stefania Padulla, Gaetano Lombardi, Vincenzo Nuzzo, Annalisa Rossi
Publikováno v:
Maturitas. 48:299-306
Background: Although overt hyperthyroidism is a well known cause of bone loss, systemic effects of subclinical hyperthyroidism (SH) are still a matter of debate. Objective: The aim of this cross-sectional study was to evaluate the effect of endogenou
Autor:
G. Valerio, R. Spadaro, A. Esposito Del Puente, A. Del Puente, F. Lombardi, F. De Terlizzi, IAFUSCO, Dario, F. Prisco, R. Troncone, A. Franzese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::a58f41a1229c28efc659ed37f5c8373e
http://hdl.handle.net/11591/209814
http://hdl.handle.net/11591/209814
Autor:
Antonella Esposito-del Puente, A. Carpinelli, Antonio Del Puente, Mariacarolina Salerno, Teresa Lettiero, S. Padula, Donatella Capalbo, Valentina Esposito
Publikováno v:
European journal of endocrinology. 151(6)
OBJECTIVE: To evaluate whether long-term l-thyroxine therapy in young adults with congenital hypothyroidism may affect bone mineral density (BMD). DESIGN: Thirty-seven subjects with congenital hypothyroidism, detected by neonatal screening and longit
Autor:
Tauchmanovà L, Nuzzo V, Fonderico F, Esposito Del Puente A, Padulla S, Rossi A, Bifulco G, DEL PUENTE, ANTONIO, LUPOLI, GIOVANNI, LOMBARDI, GAETANO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::76a2ea6ff1f54722d696b47b363d249d
http://hdl.handle.net/11588/416766
http://hdl.handle.net/11588/416766
Autor:
Enza Mozzillo, Antonio del Puente, Giuliana Valerio, P Buono, Antonella Esposito-del Puente, Adriana Franzese
Aim: To analyze whether bone mineral density (BMD) and bone resorption status are influenced by long-term metabolic control and duration of disease in adolescents with long-standing type 1 diabetes mellitus. Methods: Twenty-seven adolescents (age 13.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c169fa93b71ed87b239ab344052d154
http://hdl.handle.net/11367/24114
http://hdl.handle.net/11367/24114
Autor:
Nuzzo V, Fittipaldi MR, Fonderico F, Esposito Del Puente A, Russo D, Pagliuca A, Vitale G, Caserta A, LUPOLI, GIOVANNI, DEL PUENTE, ANTONIO
Publikováno v:
Minerva pediatrica. 51(3)
Very few studies have evaluated the role of urinary calcium excretion as marker of bone metabolism in children. Normative data are lacking in these age groups.In a group of 122 children (66 females e 56 males), mean age 108.13 +/- 18.73 months, atten
Autor:
S. Di Maio, A Esposito-Del Puente, S. Formicola, Giuliana Valerio, Franco Contaldo, A. Franzese, A Rubino
To analyze possible early abnormalities in bone resorption in type 1 diabetes mellitus the urinary excretion of the collagen crosslinks pyridinoline and deoxypyridinoline was evaluated by immunoassay in 26 prepubertal diabetic patients (mean age 7.8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e280de83dd8fc0eb577b01d461893ce7
http://hdl.handle.net/11588/486291
http://hdl.handle.net/11588/486291
Autor:
A. Esposito Del Puente, Vincenzo Nuzzo, E. Rampone, Pasquale Oriente, A. Del Puente, A. Carpinelli, Giovanni Lupoli
Publikováno v:
Scopus-Elsevier
Osteoporosis is a well-known complication of thyrotoxicosis. Prolonged subclinical hyperthyroidism due to L-thyroxine treatment has been associated with reduced bone mass and thus with the potential risk of premature development of osteoporosis. The